trifluoperazine has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Körbel, C | 1 |
| Linxweiler, M | 1 |
| Bochen, F | 1 |
| Wemmert, S | 1 |
| Schick, B | 1 |
| Meyer, M | 1 |
| Maurer, H | 1 |
| Menger, MD | 1 |
| Zimmermann, R | 1 |
| Greiner, M | 1 |
1 other study available for trifluoperazine and Carcinoma, Squamous Cell of Head and Neck
| Article | Year |
|---|---|
Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Carcinoma, Squamous Cell; Cell | 2018 |